<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Miller RJH</submitter><funding>Arthur J E Child Fellowship</funding><funding>NCATS NIH HHS</funding><funding>NHLBI</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>NHLBI NIH HHS</funding><funding>Dr. Miriam and Sheldon Adelson Medical Research Foundation</funding><funding>National Institutes of Health</funding><funding>NIH</funding><pagination>567-575</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7167750</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(5)</volume><pubmed_abstract>&lt;h4>Aims&lt;/h4>Ischaemia on single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) is strongly associated with cardiovascular risk. Transient ischaemic dilation (TID) and post-stress wall motion abnormalities (WMA) are non-perfusion markers of ischaemia with incremental prognostic utility. Using a large, multicentre SPECT MPI registry, we assessed the degree to which these features increased the risk of major adverse cardiovascular events (MACE) in patients with less than moderate ischaemia.&lt;h4>Methods and results&lt;/h4>Ischaemia was quantified with total perfusion deficit using semiautomated software and classified as: none (&lt;1%), minimal (1 to &lt;5%), mild (5 to &lt;10%), moderate (10 to &lt;15%), and severe (≥15%). Univariable and multivariable Cox proportional hazard analyses were used to assess associations between high-risk imaging features and MACE. We included 16 578 patients, mean age 64.2 and median follow-up 4.7 years. During follow-up, 1842 patients experienced at least one event. Patients with mild ischaemia and TID were more likely to experience MACE compared with patients without TID [adjusted hazard ratio (HR) 1.42, P = 0.023], with outcomes not significantly different from patients with moderate ischaemia without other high-risk features (unadjusted HR 1.15, P = 0.556). There were similar findings in patients with post-stress WMA. However, in multivariable analysis of patients with mild ischaemia, TID (adjusted HR 1.50, P = 0.037), but not WMA, was independently associated with increased MACE.&lt;h4>Conclusion&lt;/h4>In patients with mild ischaemia, TID or post-stress WMA identify groups of patients with outcomes similar to patients with moderate ischaemia. Whether these combinations identify patients who may derive benefit from revascularization deserves further investigation.</pubmed_abstract><journal>European heart journal. Cardiovascular Imaging</journal><pubmed_title>Transient ischaemic dilation and post-stress wall motion abnormality increase risk in patients with less than moderate ischaemia: analysis of the REFINE SPECT registry.</pubmed_title><pmcid>PMC7167750</pmcid><funding_grant_id>R01HL089765</funding_grant_id><funding_grant_id>UL1 TR001863</funding_grant_id><funding_grant_id>R01 HL089765</funding_grant_id><pubmed_authors>Gransar H</pubmed_authors><pubmed_authors>Miller RJH</pubmed_authors><pubmed_authors>Hu LH</pubmed_authors><pubmed_authors>Sharir T</pubmed_authors><pubmed_authors>Sinusas AJ</pubmed_authors><pubmed_authors>Ruddy TD</pubmed_authors><pubmed_authors>Tamarappoo BK</pubmed_authors><pubmed_authors>Bateman T</pubmed_authors><pubmed_authors>Berman DS</pubmed_authors><pubmed_authors>Eisenberg E</pubmed_authors><pubmed_authors>Dey D</pubmed_authors><pubmed_authors>Einstein AJ</pubmed_authors><pubmed_authors>Germano G</pubmed_authors><pubmed_authors>Carli MD</pubmed_authors><pubmed_authors>Otaki Y</pubmed_authors><pubmed_authors>Dorbala S</pubmed_authors><pubmed_authors>Kaufmann PA</pubmed_authors><pubmed_authors>Fish MB</pubmed_authors><pubmed_authors>Miller EJ</pubmed_authors><pubmed_authors>Betancur J</pubmed_authors><pubmed_authors>Slomka PJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Transient ischaemic dilation and post-stress wall motion abnormality increase risk in patients with less than moderate ischaemia: analysis of the REFINE SPECT registry.</name><description>&lt;h4>Aims&lt;/h4>Ischaemia on single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) is strongly associated with cardiovascular risk. Transient ischaemic dilation (TID) and post-stress wall motion abnormalities (WMA) are non-perfusion markers of ischaemia with incremental prognostic utility. Using a large, multicentre SPECT MPI registry, we assessed the degree to which these features increased the risk of major adverse cardiovascular events (MACE) in patients with less than moderate ischaemia.&lt;h4>Methods and results&lt;/h4>Ischaemia was quantified with total perfusion deficit using semiautomated software and classified as: none (&lt;1%), minimal (1 to &lt;5%), mild (5 to &lt;10%), moderate (10 to &lt;15%), and severe (≥15%). Univariable and multivariable Cox proportional hazard analyses were used to assess associations between high-risk imaging features and MACE. We included 16 578 patients, mean age 64.2 and median follow-up 4.7 years. During follow-up, 1842 patients experienced at least one event. Patients with mild ischaemia and TID were more likely to experience MACE compared with patients without TID [adjusted hazard ratio (HR) 1.42, P = 0.023], with outcomes not significantly different from patients with moderate ischaemia without other high-risk features (unadjusted HR 1.15, P = 0.556). There were similar findings in patients with post-stress WMA. However, in multivariable analysis of patients with mild ischaemia, TID (adjusted HR 1.50, P = 0.037), but not WMA, was independently associated with increased MACE.&lt;h4>Conclusion&lt;/h4>In patients with mild ischaemia, TID or post-stress WMA identify groups of patients with outcomes similar to patients with moderate ischaemia. Whether these combinations identify patients who may derive benefit from revascularization deserves further investigation.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 May</publication><modification>2024-02-15T08:50:33.177Z</modification><creation>2022-02-09T18:11:04.366Z</creation></dates><accession>S-EPMC7167750</accession><cross_references><pubmed>31302679</pubmed><doi>10.1093/ehjci/jez172</doi></cross_references></HashMap>